HomeAMPE • OTCMKTS
Ampio Pharmaceuticals Inc
Follow
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.22M | — |
Net income | -2.05M | — |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -2.22M | — |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.12M | — |
Total assets | 5.74M | — |
Total liabilities | 2.38M | — |
Total equity | 3.36M | — |
Shares outstanding | 1.14M | — |
Price to book | 0.00 | — |
Return on assets | -82.76% | — |
Return on capital | -115.99% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Net income | -2.05M | — |
Cash from operations | -2.31M | — |
Cash from investing | — | — |
Cash from financing | 0.00 | — |
Net change in cash | -2.31M | — |
Free cash flow | -1.73M | — |
Previous close
$0.00060
Market cap
680.00 USD
Avg Volume
77.00
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
About
Founded
2008
Headquarters
Website
Employees
6
